SOLASCURE Ltd (SolasCure), a biotechnology company developing a novel treatment to transform chronic wound healing, today announced the initiation of a new Phase II clinical trial, CLEANVLU2.
Evotec receives grant from Korean Government to develop novel antibody-based treatments for lung diseases – Biotech Investments
EQS-News: Evotec SE / Key word(s): Miscellaneous Evotec receives grant from Korean Government to develop novel antibody-based treatments for lung diseases 22.01.2025 / 07:30 CET/CEST